Table 1 Data on 17 males with Secretory Breast Cancer
Author | Year | Age | Duration of symptoms | Size (cm) | Axillary status | Treatment | Hormone Receptors | ETV6-NTRK3 | Follow-up |
|---|---|---|---|---|---|---|---|---|---|
Simpson31 | 1969 | 5 | ND | ND | - (clinical) | LE | NE | NE | NED 4y |
Tavassolli7 | 1980 | 9 | ND | ND | - (clinical) | LE | NE | NE | NED 1.75y |
Kari5 | 1985 | 3 | 1 mo | 1.5 | + (1/4) | SM+ALNS | NE | NE | ND |
Roth32 | 1988 | 23 | 21y | 2.0 | - (0/21) | MRM | NE | NE | NED 4y |
Krausz10 | 1989 | 24 | Many years | 4.0 | ND | SM + RT (axilla) | NE | NE | DOD 20y |
Serour21 | 1992 | 17 | 4 y | 1.5 | - (0/3) | WLE + ALND | ER- PR+ | NE | NED 5y |
Lamovec18 | 1994 | 20 | ND | 1.2 | - (0/?) | MRM | ER+ PR+ | NE | NED 1y |
Pohar-Marinsek33 | 1994 | 20 | 6–7 y | 1.2 | - (clinical) | SM | ER+ PR+ | NE | NED 6 m |
Kuwabara34 | 1988 | 66 | 3 y | 3.0 | + (2/?) | MRM | ER- PR+ | NE | NED 8 m |
Vesoulis35 | 1998 | 33 | 10 y | 1.5 | ND | MRM | ER+ PR+ | NE | ND |
Kameyama36 | 1998 | 50 | ND | 3.0 | - (0/?) | MRM | ER+ | NE | ND |
Chevallier37 | 1999 | 9 | 14 m | 2.0 | - (0/?) | LE + ALND | ER- PR- | NE | NED 45 m |
Yildirim38 | 1999 | 11 | 1 y | 1.5 | + (1/18) | MRT + CT+ RT | ER - | NE | NED 12 m |
Bhagwandeen39 | 1999–2000 | 9 | 1 m | 1.2 | - (0/15) | MRM | ER- PR- | NE | NED 20 m |
De Bree22 | 2001 | 17 | 2 y | 2.0 | - (0–14) | MRM | ER- PR- | NE | NED 9 m |
Grabellus40 | 2005 | 46 Male-female transexual | ND | 4.0 | ND | LE | ER- PR- | PRESENT | ND |
This case | 2005 | 52 | 10 y | 7 | + 2/24 | MRM + CT | ER- PR- | PRESENT | AWD 25 m |